… hepatectomy is important for patients with colorectal liver … of cilostazol (CZ), an oral selective
phosphodiesterase III … VWF in zone 3 and the increase in blood HA levels after hepatectomy …

… Kollmar, and MD Menger (2014) The phosphodiesterase 3 inhibitor cilostazol does not
stimulate growth of colorectal liver metastases after major hepatectomy. Clin. Exp…

… the stemness of colorectal cancer. More interestingly, it … -selective inhibitor cilostazol
reduces breast cancer cell stem cell… –metastasis environment are thought to promote breast …

… colorectal liver metastases, the possibility for radical liver resection … prevented SOS
development after HSCT (35). As it … was to evaluate whether administration of MSC can improve …

… rate of degradation by phosphodiesterases. cAMP signaling … six weeks followed by 70%
partial hepatectomy (PH) [100]. … ) and the PDE3 inhibitor, Cilostazol, on liver injury has also been …

… for colorectal liver metastases (CRLM). Clinically, the disease … ) of these adaptations will
allow us to improve our analysis and … rats underwent 70% partial hepatectomy. Similarly, in a …

… a partial hepatectomy, and it was related to hepatocyte … cancer preventatives, particularly
in the context of colorectal … with T2DM, cilostazol has demonstrated the ability to inhibit the …

… liver failure during the postoperative period after major liver resection … NO, natriuretic factors
and phosphodiesterase inhibitors, … anti-colorectal cancer drugs along the following pathways…

… -1 inhibitor (vorapaxar), phosphodiesterase III inhibitor (cilostazol) and the factor XA inhibitor
(… Mechanistically, it is found that NXT increases the catalytic activity of CYP2C19, which …

… The phosphodiesterase-3 (PDE3)-inhibitor (cilostazol) has been associated … of cilostazol
on hepatocellular damage, liver regeneration, and inflammatory status after major hepatectomy …